Real-time vascular Target hospitals and surgical centers investing in real-time tissue and vessel detection for minimally invasive procedures. Sell SafeSnips integration to enhance surgeon safety and precision during laparoscopic and robotic cutting.

Capital efficiency With revenue in the low millions and a recent funding round, approach growth-stage medical device manufacturers and early-stage medtech funding rounds for partnerships, co-development, or strategic investments.

End-user focus Directly engage surgeons, operating room directors, and procurement teams who prioritize enhanced visualization and safety in MIS. Position deployments as a differentiator for training programs and patient outcomes.

Strategic fit Align with large EFMs and device majors as potential OEM or integration partners given the SafeSnips concept. Consider pilots or co-branding with established players to accelerate market access.

Timeline opportunities Leverage the near-term roadmap for vessel detection to target early adopter centers and key thought leaders in robotic and laparoscopic surgery, enabling case studies and FDA/CE progression support.